by Fabio Giuseppe Carlo Carisio for VT Italy

US President Donald Trump revealed Friday that Gilead Sciences’ antiviral drug Remdesivir has been cleared by the Food and Drug Administration (FDA) for the treatment of COVID-19.

According to Reuters, Gilead CEO Daniel O’Day called the FDA’s emergency authorization an “important first step” and pledged to donate “1 million vials of Remdesivir.” US Vice President Mike Pence also said that 1 million vials of Remdesivir will be distributed to hospitals starting Monday.

The FDA authorization comes just two days after Gilead Sciences revealed it was aware of “positive data” from a clinical trial by the US National Institute of Allergy and Infectious Diseases of the antiviral drug as a COVID-19 treatment.

The institute is led by Anthony Fauci, one of the leading doctors assigned to the White House Coronavirus Task Force. During a Wednesday meeting in the Oval Office, Fauci indicated that the drug trial showed that Remdesivir has had a significant effect on reducing coronavirus symptoms.

Read Full Article

Author Details
Director Gospa News

Fabio is Director and Editor of Gospa News; a Christian Information Journal. Fabio Giuseppe Carlo Carisio, born on 24/2/1967 in Borgosesia, started working as a reporter since he was only 19 years old in the alpine area of Valsesia, Piedmont, his birth region in Italy. After studying literature and history at the Catholic University of the Sacred Heart in Milan, he became deputy director of a local newspaper and specialized in judicial reporting. For about 15 years he is a correspondent from Northern Italy for the Italian newspapers Libero and Il Giornale, also writing important revelations on the Ustica massacre, a report on Freemasonry and organized crime. With independent investigations he collaborates with Carabinieri and Guardia di Finanza in important investigations that conclude with the arrest of Camorra entrepreneurs or corrupt politicians. In July 2018 he found the counter-information webmedia Gospa News focused on geopolitics, terrorism, Middle East and military intelligence. He is a correspondent from Italy for the French news site Reseau International. He worked since many years for the magazine Art & Wine as art critic and curator Art-Wine.eu

DISCLOSURE: All content herein is owned by author exclusively.  Expressed opinions are NOT necessarily the views of Veterans Today Network (VTN), authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VTN.